Back to results
US 2025/0051408 A1Published application
Factor h variants for treatment of disease
AssigneeThe Trustees of the University of Pennsylvania
InventorsWenchao Song, Damodar Gullipalli, Takashi Miwa
Life of this patent
Estimating the term…
Abstract
Disclosed herein are factor H variants, vectors comprising said factor H variants, and pharmaceutical compositions comprising the same for treatment of disorders.
Claims1
A recombinant vector having packaged therein an expression cassette comprising an engineered human complement factor H (hfH) gene operably linked to expression control sequences which direct expression thereof, wherein the hfH gene encodes a soluble hfH protein variant that retains complement regulatory function, wherein the hfH variant comprises:
- short consensus repeat (SCR) 1, 2, 3, 4, 19, 20 and one or more of SCR7, 17 and/or 18, wherein the hfH gene lacks a coding sequence for at least SCR5, SCR9, SCR10, SCR11, SCR12, SCR13, SCR14, SCR15, or SCR16.
Dependencies are inferred from the claim text.